Decorin has been shown to inhibit the growth of both primary breast cancer xenografts and metastatic spread by inactivating the oncogenic ErbB2 protein in breast carcinoma cells [10] and downregulating members of the ERb tyrosine kinase family, leading to growth inhibition [10]. The gene discussed is DCN; the disease is breast carcinoma.